文献速递血液净化与透析慢性肾脏病

糖尿病血液透析患者矿物质骨代谢标志物与死亡风险

Mineral and bone metabolism markers and mortality in diabetic patients on haemodialysis.
PubMed 文献 · Nephrol Dial Transplant · 2023-01-01

COSMOS研究纳入20个欧洲国家227个透析中心的6797例患者,前瞻性观察3年,评估血清钙、磷、甲状旁腺激素(PTH)与死亡风险的关联是否受糖尿病影响。结果显示糖尿病对PTH与死亡风险的关联存在显著效应修饰(P=.011),PTH>9倍正常值时糖尿病患者死亡相对风险显著升高,而非糖尿病患者无显著关联;钙和磷的关联未见显著效应修饰。

要点

  • 糖尿病对PTH与死亡风险的关联存在显著效应修饰(P=.011)。
  • PTH>9倍正常值时,糖尿病患者死亡相对风险为1.53(95%CI 1.07-2.19),非糖尿病患者为1.17(95%CI 0.91-1.52)。
  • 钙(P=.2)与磷(P=.059)与死亡风险的关联未受糖尿病显著效应修饰。

核心结论

  • 糖尿病与非糖尿病患者中PTH与死亡相对风险的关联不同,该发现可能对慢性肾脏病-矿物质和骨异常(CKD-MBD)的诊断和治疗有相关意义。

研究设计与样本

  • COSMOS为多中心、开放队列、3年前瞻性研究,纳入20个欧洲国家227个随机选取透析中心的6797例患者。
  • 采用Cox比例风险回归模型,结合惩罚样条平滑和按KDIGO指南分类,评估死亡与钙、磷或PTH的关联,并检验糖尿病对该关联的效应修饰。

主要发现

  • 糖尿病对PTH与死亡相对风险关联的效应修饰有统计学意义(P=.011)。
  • 随PTH值升高,死亡相对风险曲线斜率在糖尿病患者比非糖尿病患者更陡,主要见于高PTH水平。
  • 血清PTH>9倍正常值时,糖尿病患者死亡相对风险为1.53(95%CI 1.07-2.19),非糖尿病患者为1.17(95%CI 0.91-1.52)。
  • 糖尿病对钙(P=.2)或磷(P=.059)与死亡相对风险关联的效应修饰无统计学意义。

关键数值与推荐

  • 血清PTH>9倍正常值:糖尿病患者死亡相对风险1.53(95%CI 1.07-2.19),非糖尿病患者1.17(95%CI 0.91-1.52)。
  • 糖尿病对PTH与死亡风险关联的效应修饰P=.011。
  • 糖尿病对钙与死亡风险关联的效应修饰P=.2,对磷的效应修饰P=.059。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Diabetic patients on haemodialysis have a higher risk of mortality than non-diabetic patients. The aim of this COSMOS (Current management of secondary hyperparathyroidism: a multicentre observational study) analysis was to assess whether bone and mineral laboratory values [calcium, phosphorus and parathyroid hormone (PTH)] contribute to this risk. METHODS: COSMOS is a multicentre, open-cohort, 3-year prospective study, which includes 6797 patients from 227 randomly selected dialysis centres in 20 European countries. The association between mortality and calcium, phosphate or PTH was assessed using Cox proportional hazard regression models using both penalized splines smoothing and categorization according to KDIGO guidelines. The effect modification of the association between the relative risk of mortality and serum calcium, phosphate or PTH by diabetes was assessed. RESULTS: There was a statistically significant effect modification of the association between the relative risk of mortality and serum PTH by diabetes (P = .011). The slope of the curve of the association between increasing values of PTH and relative risk of mortality was steeper for diabetic compared with non-diabetic patients, mainly for high levels of PTH. In addition, high serum PTH (>9 times the normal values) was significantly associated with a higher relative risk of mortality in diabetic patients but not in non-diabetic patients [1.53 (95% confidence interval 1.07-2.19) and 1.17 (95% confidence interval 0.91-1.52)]. No significant effect modification of the association between the relative risk of mortality and serum calcium or phosphate by diabetes was found (P = .2 and P = .059, respectively). CONCLUSION: The results show a different association of PTH with the relative risk of mortality in diabetic and non-diabetic patients. These findings could have relevant implications for the diagnosis and treatment of chronic kidney disease-mineral and bone disorders.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Martín-Carro B, Navarro-González JF, Ortiz A, et al. Mineral and bone metabolism markers and mortality in diabetic patients on haemodialysis. Nephrol Dial Transplant. 2023. PMID: 37349949. doi:10.1093/ndt/gfad122

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。